 SAN DIEGO, June 28, 2021 PRNewswire -- Viracta Therapeutics, Inc. Nasdaq: VIRX, a precision oncology company targeting virus-associated malignancies, today announced that it has been added as a member of the small-cap Russell 2000 Index, the all-cap Russell 3000 Index, and the Russell Microcap Index, effective upon the U.S. market open today, June 28, 2021, as part of the 2021 Russell indexes reconstitution. The 2021 annual reconstitution of the Russell indexes captured the 4,000 largest U.S. stocks as of May 7, 2021, ranking them by total market capitalization. 